Mark W. Jacobson

Mark W. Jacobson

Auto-generated profile, based on publicly available information

Mark W. Jacobson

Formerly: Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco, California, USA, Currently: Enterprise Occupational Health, Cleveland Clinic, Cleveland, Ohio, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Motor Behavior
Verified
Journal Article
Open access
TTTravis H Turner
Travis H Turner
JGJody Goldstein
Jody Goldstein
JHJoanne M. Hamilton
Joanne M. Hamilton
MJMark Jacobson
Mark Jacobson
EPEva Pirogovsky
Eva Pirogovsky
JCJody Corey-Bloom
Jody Corey-Bloom
Initiation and inhibition of saccadic eye movements has been shown to be impaired in patients with Huntington's disease (HD) and premanifest gene carriers (PMGC), and may provide biomarkers useful in tracking phenotypic change. Computerized behavioral tests of prosaccade latency and disinhibition presented to 31 non–gene carriers (NGC), 25 PMGC, and 12 HD patients. These tests provided quantitative performance measures without use of eye-tracking equipment. Significant differences on saccade tests were found, with PMGC intermediate between NGC and HD patients. Saccade latency discriminated PMGC from NGC, whereas saccade disinhibition discriminated PMGC from HD patients. Results suggest utility of behavioral saccade measures as premanifest indicators of phenoconversion in HD.

1 May 2018 in Archives of Clinical Neuropsychology
Verified
Journal Article
Open access
SJS M Jurick
S M Jurick
LCL D Crocker
L D Crocker
AKA V Keller
A V Keller
SHS N Hoffman
S N Hoffman
JBJ Bomyea
J Bomyea
AJA J Jak
A J Jak
This study examined the Minnesota Multiphasic Personality Inventory-Second Edition-Restructured Form (MMPI-2-RF) to better understand symptom presentation in a sample of treatment-seeking Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans with self-reported history of mild traumatic brain injury (mTBI). Participants underwent a comprehensive clinical neuropsychological battery including performance and symptom validity measures and self-report measures of depressive, posttraumatic, and post-concussive symptomatology. Those with possible symptom exaggeration (SE+) on the MMPI-2-RF were compared with those without (SE-) with regard to injury, psychiatric, validity, and cognitive variables. Between 50% and 87% of participants demonstrated possible symptom exaggeration on one or more MMPI-2-RF validity scales, and a large majority were elevated on content scales related to cognitive, somatic, and emotional complaints. The SE+ group reported higher depressive, posttraumatic, and post-concussive symptomatology, had higher scores on symptom validity measures, and performed more poorly on neuropsychological measures compared with the SE- group. There were no group differences with regard to injury variables or performance validity measures. Participants were more likely to exhibit possible symptom exaggeration on cognitive/somatic compared with traditional psychopathological validity scales. A sizable portion of treatment-seeking OEF/OIF Veterans demonstrated possible symptom exaggeration on MMPI-2-RF validity scales, which was associated with elevated scores on self-report measures and poorer cognitive performance, but not higher rates of performance validity failure, suggesting symptom and performance validity are distinct concepts. These findings have implications for the interpretation of clinical data in the context of possible symptom exaggeration and treatment in Veterans with persistent post-concussive symptoms.

1 December 2006 in Aging, Neuropsychology, and Cognition
Verified
Journal Article
Closed access
SWSpencer R. Wetter
Spencer R. Wetter
DDDean C. Delis
Dean C. Delis
WHWes S. Houston
Wes S. Houston
MJMark W. Jacobson
Mark W. Jacobson
ALAmy Lansing
Amy Lansing
MBMark W. Bondi
Mark W. Bondi
Demonstrations of memory changes in those at risk for Alzheimer's disease by the presence of the APOE e4 allele have been inconsistent to date. The present study went beyond traditional analyses of central tendency (i.e., group differences on mean test scores) and also conducted distribution analyses to search for subtle cognitive differences in subgroups of normal-functioning elderly persons with the APOE e4 genotype. The results of the study revealed that (a) the e4 and non-e4 groups failed to differ in terms of their mean scores on tests of memory and verbal skills; and (b) relative to the non-e4 group, the e4 subjects had significantly greater heterogeneity of variance on the memory measures but not on fundamental verbal skills. Logistic regression analyses indicated that the discrepancy in scores on the memory measures was a significant predictor of genotype group membership (82% correct classification rate). Implications of these findings for the detection of a preclinical phase of AD are discussed.

30 December 2024 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
MTMonica K. Tilly
Monica K. Tilly
JMJames E. Jr. DO McNicholas
James E. Jr. DO McNicholas
JWJeffrey D. Whitman
Jeffrey D. Whitman
JTJacqueline P. Tulsky
Jacqueline P. Tulsky
AVAllyson H. Rn Villanueva
Allyson H. Rn Villanueva
MJMark A. Jacobson
Mark A. Jacobson
Objective: Determine performance characteristics and safety outcomes of two rapid COVID-19 screening methods to inform immediate return to work (RTW) decisions while health care personnel (HCP) await results of pending confirmatory laboratory test. Methods: This is a retrospective, occupational health quality improvement study comparing screening with rapid SARS-CoV-2 nucleic acid amplification (NAAT) and antigen test. Results: Five hundred thirty-one mildly symptomatic HCP screened over 16 months. • Negative predictive values: 96.7% (95% CI 95.1%–98.3%) for the rapid NAAT, 94.8% (92.8%–96.7%) for the rapid antigen test • Rapid antigen screening estimated to prevent 627 unnecessary lost shifts versus 620 with NAAT screening. • No nosocomial transmission identified and could be excluded in all but 4 cases. Conclusions: Until more accurate affordable NAAT tests become available, antigen test screening alone addresses simultaneous needs to minimize COVID-19 transmission from symptomatic HCP and maintain an adequate workforce.